Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know
Corcept Therapeutics Incorporated (NASDAQ: CORT ) shares soared 21.95% to $113.35 after the bell on Wednesday following the announcement of second-quarter results, where both revenue and earnings per share topped analyst estimates. Revenue and EPS Sail Past Analyst Targets The California-based biopharmaceutical company